Jeff Lynn Myers - 27 Mar 2023 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Role: Chief Medical Officer
Signature: /s/ Adam T. Newman, as attorney-in-fact
Issuer symbol: XAIR
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 28 Mar 2023, 16:36:58 UTC
Next filing: 29 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XAIR	Common Stock	Award	$0	+50,000		$0.000000	50,000	27 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XAIR	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	27 Mar 2023	Common Stock	50,000	$6.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer.
F2	The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer.

Content

Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer.

The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer.